CXCL8 and colorectal carcinoma: Biasci et al. found that continuous administration of AMD3100 in microsatellite stable CRC patients induced an integrated immune response, including intra-tumoral T and NK cell accumulation and activation, and decreased serum levels of ctDNA and circulating CXCL8.